Jeroen M. Jansen

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

Mirthe E. van der Valk, Marie‐Josée J. Mangen, Max Leenders et al. · Gut · 2012 · 491 citations · Full text

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

Johannan F. Brandse, Gijs R. van den Brink, Manon E. Wildenberg et al. · Gastroenterology · 2015 · 410 citations

Inflammation, Chronic Inflammatory Diseases, Functional Gastrointestinal Disorder +6

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 334 citations

Terminal Ileitis, Gastroenterology, Multicentre Trial +4

Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

Johannan F. Brandse, Ron A. A. Mathôt, Desirée van der Kleij et al. · Clinical Gastroenterology and Hepatology · 2015 · 194 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +10

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 193 citations · Full text

Inflammation, Autoimmune Disease, Hematology +7